METTL3 and neoplasm: In skin cancers like melanoma and squamous cell carcinoma, aberrant m6A modifications are linked to tumorigenesis and progression, with dysregulation of regulators such as METTL3 and FTO enhancing tumor cell proliferation and invasion.